HeNan Sincere Biotech Co., Ltd   Report issue

For profit Phase 1 Phase 3
Founded: Beijing China (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2017
NCT04109183
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

HeNan Sincere Biotech Co., Ltd

Active Ingredients

Drugs in Phase 3 Trials (4)

Azvudine (5 trials)

efavirenz (sustiva) (2 trials)

lamivudine (epivir) (2 trials)

tenofovir (viread) (2 trials)

Drugs in Phase 1 Trials (1)

cl-197 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 5